Doctor profile · Federal record
Dr. David Weiss, MD
Rheumatology Physician (CMS: Rheumatology) · Hattiesburg, MS
- NPI 1851431159
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 40 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
15 Orleans Dr
Hattiesburg, MS 39402
(601) 582-7655
fax (601) 582-3229
Credentials & registration
- NPI registered
- February 2007 — 19 yrs on file
- Profile last updated
- September 30, 2008
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Mississippi #15589
- Medicaid
- MS #0118558
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1851431159. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
25,382
Distinct HCPCS
10
Medicare allowed
$535,255
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 10,408 | 15 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 7,021 | 75 | $23 | |
J7318 |
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 4,200 | 38 | $7 | |
J1885 |
Injection, ketorolac tromethamine, per 15 mg | 671 | 104 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 552 | 225 | $115 | |
96372 |
Injection of drug or substance under skin or into muscle | 408 | 172 | $13 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 282 | 140 | $82 | |
J1040 |
Injection, methylprednisolone acetate, 80 mg | 256 | 136 | $12 | |
20610 |
Aspiration and/or injection of fluid from large joint | 234 | 93 | $63 | |
36415 |
Insertion of needle into vein for collection of blood sample | 196 | 146 | $8 |
In context: peer comparison
Among 2 peers in Hattiesburg Rheumatology Physician, average services per provider: 2,260. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$2,082
Transactions
91
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 29 | $656.10 | |
| Ani Pharmaceuticals, INC. | 14 | $305.14 | |
| Amgen INC. | 12 | $281.77 | |
| Novartis Pharmaceuticals Corporation | 11 | $259.84 | |
| Pfizer INC. | 6 | $119.63 | |
| Aurinia Pharma U.S., INC. | 4 | $76.87 | |
| Janssen Biotech, INC. | 3 | $76.44 | |
| Fidia Pharma USA INC. | 1 | $66.99 | |
| GlaxoSmithKline, LLC. | 3 | $51.11 | |
| Genzyme Corporation | 2 | $50.40 | |
| Ucb, INC. | 2 | $37.09 | |
| Mallinckrodt Hospital Products INC. | 1 | $32.69 | |
| Lilly USA, LLC | 1 | $24.57 | |
| Fresenius Kabi USA, LLC | 1 | $22.22 | |
| Medtronic, INC. | 1 | $21.20 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,839
Patients
391
Total drug cost
$531,426
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 258 | 48 | $6,376 |
| Gabapentin | Generic | 241 | 46 | $3,873 |
| Prednisone | Generic | 164 | 43 | $1,447 |
| Diclofenac Sodium | Generic | 155 | 37 | $1,848 |
| Tramadol Hcl | Generic | 143 | 31 | $812 |
| Meloxicam | Generic | 131 | 36 | $571 |
| Tizanidine Hcl | Generic | 114 | 34 | $1,501 |
| Leflunomide | Generic | 105 | 22 | $4,921 |
| Duloxetine Hcl | Generic | 95 | 16 | $1,061 |
| Pregabalin | Generic | 86 | 11 | $2,669 |
Frequently asked questions
What is Dr. David Weiss's medical specialty?
Dr. David Weiss practices Rheumatology Physician in Hattiesburg, MS.
Where does Dr. David Weiss practice?
Dr. David Weiss practices at 15 Orleans Dr, Hattiesburg, MS 39402. Office phone: 6015827655.
What is Dr. David Weiss's NPI?
Dr. David Weiss's National Provider Identifier (NPI) is 1851431159, issued by NPPES.
Does Dr. David Weiss accept Medicare assignment?
Yes. Dr. David Weiss accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Weiss commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, denosumab, 1 mg (HCPCS J0897); Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg (HCPCS J7318). Source: CMS Medicare Physician & Other Practitioners file.